Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Clodronic Acid Disodium Salt API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clodronic Acid Disodium Salt manufacturer or Clodronic Acid Disodium Salt supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clodronic Acid Disodium Salt manufacturer or Clodronic Acid Disodium Salt supplier.
PharmaCompass also assists you with knowing the Clodronic Acid Disodium Salt API Price utilized in the formulation of products. Clodronic Acid Disodium Salt API Price is not always fixed or binding as the Clodronic Acid Disodium Salt Price is obtained through a variety of data sources. The Clodronic Acid Disodium Salt Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bonefos manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bonefos, including repackagers and relabelers. The FDA regulates Bonefos manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bonefos API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bonefos manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bonefos supplier is an individual or a company that provides Bonefos active pharmaceutical ingredient (API) or Bonefos finished formulations upon request. The Bonefos suppliers may include Bonefos API manufacturers, exporters, distributors and traders.
click here to find a list of Bonefos suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bonefos DMF (Drug Master File) is a document detailing the whole manufacturing process of Bonefos active pharmaceutical ingredient (API) in detail. Different forms of Bonefos DMFs exist exist since differing nations have different regulations, such as Bonefos USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bonefos DMF submitted to regulatory agencies in the US is known as a USDMF. Bonefos USDMF includes data on Bonefos's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bonefos USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bonefos suppliers with USDMF on PharmaCompass.
A Bonefos CEP of the European Pharmacopoeia monograph is often referred to as a Bonefos Certificate of Suitability (COS). The purpose of a Bonefos CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bonefos EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bonefos to their clients by showing that a Bonefos CEP has been issued for it. The manufacturer submits a Bonefos CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bonefos CEP holder for the record. Additionally, the data presented in the Bonefos CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bonefos DMF.
A Bonefos CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bonefos CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bonefos suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bonefos as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bonefos API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bonefos as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bonefos and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bonefos NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bonefos suppliers with NDC on PharmaCompass.
Bonefos Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bonefos GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bonefos GMP manufacturer or Bonefos GMP API supplier for your needs.
A Bonefos CoA (Certificate of Analysis) is a formal document that attests to Bonefos's compliance with Bonefos specifications and serves as a tool for batch-level quality control.
Bonefos CoA mostly includes findings from lab analyses of a specific batch. For each Bonefos CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bonefos may be tested according to a variety of international standards, such as European Pharmacopoeia (Bonefos EP), Bonefos JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bonefos USP).
